Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 11 Lung Neoplasms 7 Colonic Neoplasms 5 Pancreatic Neoplasms 3 Pain, Postoperative 3 Inflammatory Bowel Diseases 3 Diverticulitis 3 Carcinoma, Hepatocellular 3 Urinary Bladder Neoplasms 2 Male Urogenital Diseases 2 Leiomyoma 2 Inflammation 2 Carcinoma, Non-Small-Cell Lung 2 Agnosia 2 Abdominal Cancer 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Skin Neoplasms 1 Shoulder Pain 1 Respiration Disorders 1 Psychological Well-Being 1 Postoperative Complications 1 Post-thoracotomy Pain Syndrome 1 Pleural Diseases 1 Neoplasms 1 Mouth Neoplasms 1

Interventions

Transcranial Direct Current Stimulation 1 Tea 1 Saline Solution 1 Ropivacaine 1 Probiotics 1 Ethanol 1 Cryotherapy 1 Cryosurgery 1 Bulk Drugs 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Abdominal Pain × Tea × Clear all

NCT03453424 2020-03-23

Analgesic Efficacy of Dexmedetomidine Added to Fentanyl in PCEA

South Egypt Cancer Institute

Phase 2/3 Completed

Abdominal Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡